Canada Markets closed

Mauna Kea Technologies SA (MKEAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.55000.0000 (0.00%)
At close: 01:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.5500
Open0.5500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5500 - 0.5500
52 Week Range0.5500 - 1.4000
Volume5,000
Avg. Volume79
Market Cap23.051M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)-0.5040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Mauna Kea Technologies Postpones Release of its 2022 Half-Year Financial Results

    PARIS & BOSTON, September 20, 2022--Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio®, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, postpones release of its 2022 Half-Year Results, which was originally planned for September 22, 2022, to not later than October 31, 2022.

  • Business Wire

    On Target Laboratories and Mauna Kea Technologies Further Explore Targeted Detection and Real-Time Diagnosis of Lung Cancer with a Molecular Imaging Agent

    WEST LAFAYETTE, Ind. & PARIS & BOSTON, July 26, 2022--Regulatory News: On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Euronext: MKEA, ‘Mauna Kea’) (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced publication of a study entitled

  • Business Wire

    Mauna Kea Technologies Announces Q2 and 1H 2022 Revenues

    PARIS & BOSTON, July 21, 2022--Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio®, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced its revenues for the second quarter and first half of 2022 ended June 30, 2022.